A Tale of Two Drugs: Money vs. Medical Wisdom

by | May 5, 2020 |

Print Friendly, PDF & Email

At the Presidential Briefing on April 30, Dr. Anthony Fauci announced early results, prior to peer-review, of one clinical trial using remdesivir, an intravenous (IV) experimental antiviral medicine in patients hospitalized with SARS-CoV-2 (COVID-19). At the “warp speed” currently in vogue for the Fauci-led push to a new vaccine, the very next day the FDA issued a Emergency Use Authorization for remdesivir to be used for IV treatment in seriously ill hospitalized US patients. To announce the emergency approval, President Trump met with the CEO of the drug’s manufacturer, Gilead Sciences, in the Oval Office.
Such rapid emergency use authorization is quite unusual with the FDA. Unlike the experimental remdesivir with no prior FDA approval, hydroxychloroquine (HCQ) was first approved in 1955 for malaria, and later FDA-approved for Lupus and rheumatoid arthritis. HCQ has been used in hundreds of millions of prescriptions around the world over the last 65 years. But it took two months from reports that China and South Korea were having success treating the novel coronavirus with HCQ before the FDA issued its March 28 Emergency Use Authorization for HCQ use in hospitalized COVID-19 patients. 
In truth the recent “emergency authorization” for HCQ did not expand its availability but imposed restrictions to prevent non-hospitalized patients from accessing the government’s stockpile of the drug.
Democrat Governors Cuomo (NY), Sisolak (NV), and Whitmer (MI), then led the movement with the most restrictive orders limiting HCQ to hospital use, but this has tragically expanded in some form to all but four states.
For decades of clinical use, HCQ has shown an impressive overall safety record. CDC website states HCQ has relatively minor side effects overall. Irregular heart rhythm and or retinopathy occur rarely, usually with high doses used long term. FDA shows only 62 cardiac deaths attributed to HCQ out of more than 50 million prescriptions, 0.000124%, or 1.2 out of each 1 million prescriptions. Rheumatology guidelines for Lupus and Rheumatoid Arthritis do not even require baseline electrocardiograms before prescribing HCQ, since the risk is historically minimal.

Approximately $70 million in US taxpayer funding began Gilead’s partnership with the US Army, CDC, and NIH to develop remdesivir initially for treating Ebola, but it failed to show benefit and was shelved. Yet it is primarily Gilead shareholders who will benefit from remdesivir sales for COVID-19. 

Early results of the first clinical trial of remdesivir against placebo in coronavirus were announced at the White House April 30, and showed modest benefits, according to The New York Times. Patients given remdesivir were discharged 4 days sooner than patients given placebo, though no criteria were given for determining improvement. 
There was no statistical difference in the death rate of patients in the trial. However, about 25% of patients receiving remdesivir had potentially severe side effects, including multiple organ dysfunction, septic shock, acute kidney injury, low blood pressure. Gilead’s own press release revealed the side effect of acute respiratory failure in 6% of patients in the remdesivir 5-day treatment group, and 10.7% of patients in the 10-day treatment group, clearly ominous findings with a drug designed to treat respiratory failure caused by COVID-19.
Dr. Steven Nissen, Cleveland Clinic cardiologist who has conducted dozens of clinical trials explained to The New York Times: “The disclosure of trial results in a political setting, before peer review or publication, is very unusual. Scientists will need to see figures on harms associated with the drug in order to assess its benefits…This is too important to be handled in such a sloppy fashion.” 
Dr. Michele Barry, a global health expert at Stanford University, expressed concern about Dr. Fauci’s overly enthusiastic praise for remdesivir: “It is unusual to call a drug the ‘standard of care’ until peer review of data and publication, and before studies have shown benefit in mortality.
The leading communicable disease specialist in France, Professor Didier Raoult asked about another odd aspect of the remdesivir trial: “Could Anthony Fauci explain why the investigators of the NIAID remdesivir trial did change the primary outcome during the course of the project?” Death as the primary outcome was moved to a secondary outcome, and days to recovery became the primary trial outcome. Changing the primary outcome for a clinical trial before trial results are completed is also highly unusual, a process researchers call “p-hacking.” 
In contrast, the multi-country compilation of evidence on hydroxychloroquine and azithromycin in treatment of COVID-19 (updated April 27, 2020) has consistently shown that these older medicines prevent infections, significantly reduce severity of illness once exposed, reduce viral load and duration of infectivity, reduce number of hospitalizations, reduce ventilator use and markedly reduce deaths. The data is far beyond “anecodotal” as Dr. Fauci dismissively called it.
Money appears to be trumping medical wisdom in the recent enthusiasm for remdesivir based on just one study with modest results. One naturally wonders if this may have anything to do with the fact that the “world’s largest asset manager,” BlackRock, owns nearly 10% of all Gilead stock? BlackRock’s influence in DC is legendary, and it recently was awarded the financial crown jewel of administering the Federal Reserve’s $4.5 Trillion COVID loan bail out program. 
Is someone stacking the deck in Gilead’s favor? Fully nine of the experts on the NIH COVID 19 Panel recommending treatment options have disclosed financial support from Gilead Sciences, maker of remdesivir. Why did these nine experts not recuse themselves? It raises the question of financial conflicts of interest affecting medical decisions when they recommend against HCQ, the older, safer, cheaper medicine used successfully for COVID-19 yet then recommend for use of remdesivir, the new, expensive experimental medicine on the basis of one clinical trial not yet peer reviewed.
Hydroxychloroquine on the other hand has been off patent for decades, and is available from a dozen US generic manufacturers, and also produced in China, India, Israel and other countries. HCQ costs the patient on average less than $10.00 (range 37-63 cents per tablet), for the usual 5-7 day course of treatment recommended worldwide in COVID-19. Remdesivir costs upwards of $1000, plus has added costs of having to be hospitalized to receive it.
In addition to HCQ’s low cost, major pharmaceutical companies (Novartis, Bayer, Teva, and others) have donated nearly 50 million doses to the National Stockpile.

Tragically for Americans sick with COVID-19, most of this medicine still sits in warehouses due to State Governors intervening and overruling FDA policy allowing doctors to use HCQ off-label for outpatients when it has greatest effect. 

The bottom line? Once again patient lives are being sacrificed on the altar of financial interests and elite DC powerbrokers instead of being entrusted to the judgment of patients own physicians who know them best. We are witnessing the deadly consequences of bureaucrats and governors practicing medicine without a license. 
Money over medical wisdom, and politics above patients: two viruses more lethal than COVID-19.

DrLee4America

Elizabeth Lee Vliet MD is President and CEO of Truth for Health Foundation, a 501(c)(3) public charity (www.TruthForHealth.org) advocating for early COVID home-based treatment, vaccine risks updates, and medical freedom. Dr. Vliet is also an independent practicing physician founder of Vive Life Center in Tucson and Dallas treating COVID patients and vaccine-injured patients. She is co-author with Peter A. McCullough MD MPH of the COVID Early Treatment Guide: Options to Stay Out of Hospital and Save Your Life (https://www.truthforhealth.org/patientguide/patient-treatment-guide/). Dr. Vliet is a 2014 Ellis Island Medal of Honor recipient, a past Board of Directors member of The Association of American Physicians and Surgeons (AAPS), and member of AAPS editorial writing team since 2009.

Use the code ‘OUTLOUD’ and save 15%
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments

Disclaimer: The information contained in this website is for educational, general information, and entertainment purposes only and is never intended to constitute medical or legal advice or to replace the personalized care of a primary care practitioner or legal expert.

While we endeavor to keep this information up to date and correct, the information provided by America Out Loud, its website(s), and any properties (including its radio shows and podcasts) makes no representations, or warranties of any kind, expressed, or implied, about the completeness, accuracy, reliability, suitability, or availability with respect to its website(s) or the information, products, services or related graphics and images contained on the website(s) for any purpose.

The opinions expressed on the website(s), and the opinions expressed on the radio shows and podcasts, are the opinions of the show hosts and do not necessarily represent the opinions, beliefs, or policies of anyone or any entity we may endorse. Any reliance you place on such information is therefore strictly at your own risk.

At no time, nor in any event, will we be liable for any loss, or damage, including without limitation, indirect or consequential loss of data or profits arising out of, in an association of, or connection with the use of this website.

Through this website, users can link to other websites that may be listed. Those websites are not under the control of America Out Loud or its brands. We have no control over the nature, content, or availability of those sites. America Out Loud has no control over what the sites do with the information they collect. The inclusion of any links does not necessarily imply a recommendation, nor does it endorse the views expressed with or by them.

Every effort is made to keep the website up and running smoothly. However, America Out Loud takes no responsibility for, nor are we, and will not be liable for being temporarily unavailable due to technical difficulties beyond our control. America Out Loud does not sell, trade, nor market email addresses or other personal data.

The Power to Shape the Narrative is the Power to Control the Outcome

The Power to Shape the Narrative is the Power to Control the Outcome

Setting up the “Disinformation Board” and rolling it out under the DHS moved the “Overton Window” of conceivable action closer to the Marxist ideal of information control. While they’d have liked to “legitimize” their influence on media companies with edicts from a DHS Board, the ideological alignment of the major media companies is already working steadily to undermine…

The Mastery of Projective Identification

The Mastery of Projective Identification

Just listen to Biden gloating that his administration is very successful. Is Biden not the perfect example? All that is going wrong under his watch – although Democrats are the majority in the House and Senate and the Presidency – Joe Biden blames citizen Trump, Putin, or any ‘other’ entity but NOT himself…

Pennsylvania Politics Takes a Surprising Turn 

Pennsylvania Politics Takes a Surprising Turn 

Even more shocking is that McCormick and Oz came in paying about $200 per vote received, with Barnette averaging $16 per vote, and she is almost within five percent of the vote with the other two. t was certainly the race of the decade with some unexpected turns. Other upsets include Senator Doug Mastriano winning the gubernatorial race upsetting…

Exposing Russia as a Military Fraud, Is China Next?

Exposing Russia as a Military Fraud, Is China Next?

If we had looked closely in those intervening years, we could have seen the clues of their demise. Many in my field (CE/CI) did, but the world had changed. Politicians facing the prospective loss of political control through fear-mongering of something ⏤ Russia then and China now ⏤ limited any real responses that could have achieved a safe world with Russia in it…

Take a Look at the Positive Side of Anarchy

Take a Look at the Positive Side of Anarchy

The only way to achieve liberty and peace is to restore law and order. And the only way to restore law and order is to literally crush the forces of evil. When that begins to happen, we do actually see the positive side of tyranny and anarchy. Conflict is a bedfellow of oppression. Therefore we must end the conflict and, in doing so, end the tyranny. Here’s the positive side of this war…

It’s a LONG-HAUL with COVID-19

It’s a LONG-HAUL with COVID-19

The context is that about 50% of those hospitalized with COVID-19 develop post-COVID symptoms. Severe outpatients also are affected. Characteristic symptoms include headache, hearing loss, tinnitus, loss of olfactory function, sleep disturbance, muscle aches, weakness, fatigue, and chest or abdominal pain…

Be the One.

Be the One.

Be the one — no longer willing to huddle together in the helpless band — the one who dares to join the fight. Another will follow you and then another, and in a flash of time, that bleeding hulk of our nation — once the great light of liberty to the world, now barely flickering — will rise again to throw off the wolves like it has done before, sending them scurrying for safety…

Major Medical Mystery: Why Some People Despite Exposure Don’t Get COVID

Major Medical Mystery: Why Some People Despite Exposure Don’t Get COVID

A small fraction of Americans have escaped COVID infection. CDC uses a figure of 60% for those infected, while the Institute for Health Metrics and Evaluation at the University of Washington says that 76% have been infected. The remainder may have escaped exposure or been exposed but escaped infection. The latter people are the subject of the medical mystery…

America Out Loud 6 years

Celebrating 6 incredible years fighting to restore liberty and justice to our beloved America.

Your Source for Free Speech, Talk Radio, Podcasts, and News.

 

Here we take on the challenges of our generation so that we can preserve future generations. Please consider making a contribution in the fight for liberty!

iHeartRadio

The APPS are free; the mission is priceless!

Free APP
Healthycell

Podcast Networks

Apple Podcasts
Google Podcasts
Spotify
Pandora
Tunein
iHeart
Stitcher

Subscribe and Listen on Your Favorite APP

Our Columnists and Show Hosts

Truth For Health

Apple Podcasts

COVID Solution Summit

Apple Podcasts

Evacuating Americans & fully-vetted Afghan's at Risk - Help Us!

Apple Podcasts

Empowering and mentoring conservative trailblazers from Generation Z to win!

Apple Podcasts

Turning Point Action is Recruiting Precinct Chairs - Become a Grassroots Warrior Today!

Apple Podcasts

URGENT - KEEP NINE
Please join us to protect the Supreme Court:
Sign the Petition!

Apple Podcasts

The LATINO USA EXIT from the Democrat Party, click for details...

Apple Podcasts

Fighting corporate censorship and ensuring voter integrity...

Apple Podcasts

Support wounded and fallen police officers. The Wounded Blue.

Wounded Blue
Share via
Copy link